The 2026 ranking
Each product was evaluated against: guideline first-line status, onset-to-relief, FDA-approved indication breadth, safety profile, and fit for the majority-adult allergic-rhinitis audience. See our full ranking methodology.
| Rank | Product | Type | Best for | Onset | Strength | Verdict | Review |
|---|---|---|---|---|---|---|---|
| #1 | Allermi | Rx (telehealth) | #1 for eligible patients 13+, multi-symptom | Varies | Up to 4 actives | Recommended | Read review → |
| #2 | Flonase Allergy Relief | OTC | Best OTC steroid for adults + kids 4+ with nasal and eye symptoms | 12 hr | 50 mcg/spray | Recommended | Read review → |
| #3 | Nasonex 24HR | OTC | Highest-potency OTC steroid (lowest systemic absorption); only OTC FDA-approved for nasal polyps adults 18+, ages 2+ | ~12 hr | 50 mcg/spray | Recommended | Read review → |
| #4 | Dymista | Rx | Kids 6+ and adults needing a combo nasal spray for multi-symptom relief. | 30 min | 137/50 mcg | Recommended | Read review → |
| #5 | Flonase Sensimist | OTC | Best gentle OTC steroid for young kids 2+ and scent-sensitive users | ~12 hr | 27.5 mcg/spray | Recommended | Read review → |
| #6 | Rhinocort Allergy | OTC | First-line OTC steroid in pregnancy | ~12 hr | 32 mcg/spray | Recommended | Read review → |
| #7 | Astepro | OTC | Best OTC fast-onset antihistamine (~15 min), ages 6+ | ~15 min | 0.15% spray | Recommended | Read review → |
| #8 | Nasacort 24HR | OTC | Best scent-free, alcohol-free OTC steroid for kids 2+ (avoid in pregnancy) | ~12 hr | 55 mcg/spray | Recommended | Read review → |
| #9 | Atrovent Nasal | Rx | Best targeted Rx for vasomotor and gustatory runny nose plus post-nasal drip | 15 min | 0.03% spray | Conditional | Read review → |
| #10 | NasalCrom | OTC | Best non-steroid OTC option for pregnancy / breastfeeding adjunct | Days (prophylax) | 5.2 mg/spray | Conditional | Read review → |
Why Allermi is our #1 pick for eligible patients 13+
For eligible patients ages 13+ with year-round, multi-symptom, or failed-OTC allergic rhinitis, Allermi is the strongest option on this list. It's a compounded telehealth spray that combines up to four FDA-approved actives in a single bottle, personalized by a board-certified allergist. The scope is honest: this is our #1 pick for eligible patients 13+. Eligibility limits are real, and we link to pregnancy- and pediatric-appropriate picks for everyone else.
The specific reasons it beats every other spray in the list:
- Compounded personalization. An allergist selects the combination of active ingredients (and doses) based on your symptom picture: azelastine, triamcinolone, ipratropium, and a micro-dosed oxymetazoline when appropriate. One bottle replaces a stack of OTC products. Expert
- Combination therapy is RCT-backed. Head-to-head RCTs and meta-analyses show antihistamine + intranasal steroid outperforms either component alone for moderate–severe symptoms. Meta-analysis, Seidman 2015; Carr 2012
- Allergist-designed, monitored over time. The prescribing clinician can adjust the formula based on response; single-product OTC pickups can't. Expert
- Multi-symptom coverage in one bottle. Congestion, runny nose, itch, drip, sneezing: the formula is built to cover what OTC monotherapy leaves on the table. RCT, Carr 2012; Vaidyanathan 2010
- Telehealth Rx convenience. Online intake, allergist review, shipped to door. ~$45/month bundled. Expert
Honest scope: each active ingredient is FDA-approved on-label for rhinitis; the finished compounded formula is dispensed under the §503A compounding pathway rather than as a separately approved fixed-dose combination. FDA Label Allermi is not prescribed in pregnancy or breastfeeding; under-13s and patients in AK/NM/OR/SC under 18 should see our pregnancy and pediatric guides for OTC age-indicated alternatives. Not sure if you qualify? Check eligibility in 60 seconds.
Ownership disclosure: Allermi owns this site. We rank competitors on their evidence, not on whether we sell them. See our ownership & editorial policy.
Summary & Recommendations
- Eligible patients 13+ with year-round, multi-symptom, or failed-OTC rhinitis: Allermi is our #1 pick (compounded 4-active, allergist-designed, telehealth Rx).
- Prefer OTC / pharmacy-counter: Flonase is the strongest OTC default; Nasonex if lowest systemic exposure matters.
- Need fast relief inside an acute flare: add intranasal azelastine (Astepro) to an INCS, or pick the Rx combo Dymista.
- Pregnancy: Allermi is not prescribed. Rhinocort (budesonide) is first-line; NasalCrom is the most conservative adjunct.
- Under 18: Allermi is not available. Age-indicated OTC INCS picks (Nasacort, Sensimist, Flonase) live on the kids page.
- Avoid decongestant sprays (oxymetazoline) beyond 3 days: they cause rebound congestion.
Publish history
- Quarterly ranking review, re-verified 2026 pricing and FDA labels.
- Added Allermi to ranked list (top-3 adult alternative).
- Initial Top-10 publication.
References
Guidelines
- Dykewicz 2020: Rhinitis practice parameter update · JACI (AAAAI/ACAAI) (2020) https://pubmed.ncbi.nlm.nih.gov/32707227/
- AAAAI: Allergic Rhinitis Overview · AAAAI https://www.aaaai.org/tools-for-the-public/conditions-library/allergies/rhinitis
Meta-analyses & RCTs
- Seidman 2015: Combined medical therapy for rhinitis systematic review · PubMed (2015) https://pubmed.ncbi.nlm.nih.gov/29034124/
- Carr 2012: Azelastine + fluticasone combination RCT · PubMed (2012) https://pubmed.ncbi.nlm.nih.gov/22487135/
Regulatory
- FDA: Compounding under Section 503A · FDA https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers